SCHEMBL5282679

SCHEMBL5282679

CN(C)c1ccc(NC(=O)N2CCC(CCNC(=O)COCc3ccc(F)cc3)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
KMT2A Q03164 4/20 0.43
GAA P10253 2/20 0.43
MEN1 O00255 1/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ESR2 Q92731 1/20 0.43
ALOX15 P16050 1/20 0.42
CHRM4 P08173 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
NAMPT P43490 2/20 0.41
TPSAB1 Q15661 1/20 0.41
TPSD1 Q9BZJ3 1/20 0.41
TPSG1 Q9NRR2 1/20 0.41
CYP1A2 P05177 1/20 0.41
EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5291871 0.88 FAAH (0.51) ALDH1A1KMT2AGAAMEN1SMN1; SMN2
SCHEMBL5279924 0.88 KMT2A (0.48) KMT2AGAACHRM4CYP2C9CYP2C19
SCHEMBL5277951 0.88 GRIN2B (0.43) ALDH1A1KMT2ASMN1; SMN2CHRM4TPSAB1
SCHEMBL5282756 0.85 RAB9A (0.50) ALDH1A1KMT2AGAAMEN1SMN1; SMN2
SCHEMBL5292648 0.84 L3MBTL1 (0.49) KMT2AGAASMN1; SMN2MAPTNAMPT
SCHEMBL5281167 0.80 L3MBTL1 (0.48) KMT2AGAASMN1; SMN2MAPTNAMPT
SCHEMBL5280999 0.79 POLB (0.50) ALDH1A1CHRM4POLBTPSAB1TPSD1
SCHEMBL6038154 0.79 SMO (0.40) KMT2ASMN1; SMN2CHRM4MAPTTPSAB1
SCHEMBL5289399 0.77 LMNA (0.47) ALDH1A1KMT2AGAAMEN1SMN1; SMN2
SCHEMBL5279075 0.76 WNT3 (0.45) ALDH1A1KMT2AMEN1CHRM4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863804-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2007-12-12 EP claimed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US claimed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO claimed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 ALDH1A1 781/4885KMT2A 30/4885GAA 569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.